Difference in Neutropenia due to Administration Schedule of TAS-102

TAS-102 significantly improves overall survival in patients with metastatic colorectal cancer. The most common adverse event of TAS-102 is bone marrow suppression, which leads to neutropenia. The incidence of neutropenia is high, and there is no known effective prevention method. Furthermore, the ad...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Case Rep Oncol
Autors principals: Yoshida, Yoichiro, Aisu, Naoya, Mogi, Ai, Komono, Akira, Sakamoto, Ryohei, Kojima, Daibo, Mera, Toshiyuki, Hasegawa, Suguru
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2017
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5465677/
https://ncbi.nlm.nih.gov/pubmed/28611635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000460242
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars